MEC2 best recapitulates the characteristics of primary CLL cells in terms of TLR9 signaling, IkBz expression, and global molecular fingerprint, pointing to this cell line as the most appropriate preclinical model to study TLR stimulation in CLL. This evidence concerns the gene NFKBIZ and B-cell chronic lymphocytic leukemia.